EVALUATION OF THE EFFECT OF TOLVAPTAN ON OXIDATIVE STRESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

被引：0
|
作者：
Rigato, Matteo [1 ]
Bertoldi, Giovanni [1 ]
Ravarotto, Verdiana [1 ]
Carraro, Gianni [1 ]
Calo, Lorenzo [1 ]
机构：
[1] Univ Padua, Dept Med, Nephrol Dialysis & Transplantat Unit, Padua, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO022
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD)
    Boyano, Iris Viejo
    Velasco, Paul Jose Hernandez
    Martinez, Eduardo Gutierrez
    NEFROLOGIA, 2024, 44 (02): : 301 - 303
  • [22] IDENTIFYING THE MAIN PREDICTORS OF URINE OUTPUT IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS TAKING TOLVAPTAN
    Borrego-Utiel, Francisco-Jose
    Morales Garcia, Ana Isabel
    Polo Moyano, Aurora
    Roca Oporto, Francisco
    Merino Garcia, Enoc
    Esteban de la Rosa, Rafael Jose
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I4 - I4
  • [23] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Reply
    Torres, Vicente E.
    Gansevoort, Ron T.
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1259 - 1259
  • [24] Autosomal dominant polycystic kidney disease (ADPKD) in children
    Crocker, J.
    Acott, P.
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1653 - 1653
  • [25] Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
    Baur, Brian P.
    Meaney, Calvin J.
    PHARMACOTHERAPY, 2014, 34 (06): : 605 - 616
  • [26] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    DRUGS, 2019, 79 (03) : 303 - 313
  • [27] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2015, 75 : 1797 - 1806
  • [28] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Drugs, 2019, 79 : 303 - 313
  • [29] An update on tolvaptan for autosomal dominant polycystic kidney disease
    Poch, E.
    Rodas, L.
    Blasco, M.
    Molina, A.
    Quintana, L.
    DRUGS OF TODAY, 2018, 54 (09) : 519 - 533
  • [30] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Blair, Hannah A.
    Keating, Gillian M.
    DRUGS, 2015, 75 (15) : 1797 - 1806
12345